| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9320103 | European Urology | 2005 | 5 Pages |
Abstract
Treatment delay in the investigated time span of a few months did not adversely affect recurrence free survival rates. Patients can be reassured that they can evalute treatment options without compromising efficacy due to a delay in treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Markus Graefen, Jochen Walz, K.-H.F. Chun, Thorsten Schlomm, Alexander Haese, Hartwig Huland,